These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19369567)

  • 21. The transient receptor potential cation channel subfamily V members 1 and 2, P2X purinoceptor 3 and calcitonin gene-related peptide in sensory neurons of the rat trigeminal ganglion, innervating the periosteum, masseter muscle and facial skin.
    Sato M; Sato T; Yajima T; Shimazaki K; Ichikawa H
    Arch Oral Biol; 2018 Dec; 96():66-73. PubMed ID: 30195141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
    Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
    Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology.
    Thalakoti S; Patil VV; Damodaram S; Vause CV; Langford LE; Freeman SE; Durham PL
    Headache; 2007; 47(7):1008-23; discussion 24-5. PubMed ID: 17635592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
    Durham PL; Cady R; Cady R
    Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain.
    Dolly JO; O'Connell MA
    Curr Opin Pharmacol; 2012 Feb; 12(1):100-8. PubMed ID: 22188874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization.
    Cady RJ; Glenn JR; Smith KM; Durham PL
    Mol Pain; 2011 Dec; 7():94. PubMed ID: 22145886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
    McDonald HA; Neelands TR; Kort M; Han P; Vos MH; Faltynek CR; Moreland RB; Puttfarcken PS
    Eur J Pharmacol; 2008 Oct; 596(1-3):62-9. PubMed ID: 18755179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from rat trigeminal ganglion: evidence for intraganglionic neurotransmission.
    Ulrich-Lai YM; Flores CM; Harding-Rose CA; Goodis HE; Hargreaves KM
    Pain; 2001 Apr; 91(3):219-226. PubMed ID: 11275377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OnabotulinumtoxinA effects on trigeminal nociceptors.
    Moore AA; Nelson M; Wickware C; Choi S; Moon G; Xiong E; Orta L; Brideau-Andersen A; Brin MF; Broide RS; Liedtke W; Moore C
    Cephalalgia; 2023 Feb; 43(2):3331024221141683. PubMed ID: 36751871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical effects of photobiostimulation in the trigeminal ganglion after inferior alveolar nerve injury.
    Martins DO; Santos FM; Britto LR; Lemos JB; Chacur M
    J Biol Regul Homeost Agents; 2017; 31(1):147-152. PubMed ID: 28337884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons.
    Diogenes A; Ferraz CC; Akopian AN; Henry MA; Hargreaves KM
    J Dent Res; 2011 Jun; 90(6):759-64. PubMed ID: 21393555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study.
    Edvinsson J; Warfvinge K; Edvinsson L
    J Headache Pain; 2015; 16():555. PubMed ID: 26245187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A.
    Shimizu T; Shibata M; Toriumi H; Iwashita T; Funakubo M; Sato H; Kuroi T; Ebine T; Koizumi K; Suzuki N
    Neurobiol Dis; 2012 Dec; 48(3):367-78. PubMed ID: 22820141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibronectin stimulates TRPV1 translocation in primary sensory neurons.
    Jeske NA; Patwardhan AM; Henry MA; Milam SB
    J Neurochem; 2009 Feb; 108(3):591-600. PubMed ID: 19012739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium entry via TRPV1 but not ASICs induces neuropeptide release from sensory neurons.
    Boillat A; Alijevic O; Kellenberger S
    Mol Cell Neurosci; 2014 Jul; 61():13-22. PubMed ID: 24794232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels.
    Kleeberg-Hartmann J; Vogler B; Messlinger K
    J Headache Pain; 2021 Apr; 22(1):23. PubMed ID: 33849430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion.
    Price TJ; Louria MD; Candelario-Soto D; Dussor GO; Jeske NA; Patwardhan AM; Diogenes A; Trott AA; Hargreaves KM; Flores CM
    BMC Neurosci; 2005 Jan; 6():4. PubMed ID: 15667652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose phenylephrine increases meningeal blood flow through TRPV1 receptor activation and release of calcitonin gene-related peptide.
    Dux M; Babes A; Manchen J; Sertel-Nakajima J; Vogler B; Schramm J; Messlinger K
    Eur J Pain; 2020 Feb; 24(2):383-397. PubMed ID: 31661581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRESK background potassium channel modifies the TRPV1-mediated nociceptor excitability in sensory neurons.
    Lengyel M; Hajdu D; Dobolyi A; Rosta J; Czirják G; Dux M; Enyedi P
    Cephalalgia; 2021 Jun; 41(7):827-838. PubMed ID: 33525904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inefficient constitutive inhibition of P2X3 receptors by brain natriuretic peptide system contributes to sensitization of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine.
    Marchenkova A; Vilotti S; Ntamati N; van den Maagdenberg AM; Nistri A
    Mol Pain; 2016; 12():. PubMed ID: 27175010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.